PreveCeutical Medical (FRA:18H0) EBITDA Margin %: 0.00% (As of Dec. 2025)


What is PreveCeutical Medical EBITDA Margin %?

PreveCeutical Medical FRA:18H0 EBITDA Margin % is 0.00% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 943 Biotechnology companies, PreveCeutical Medical ranks worse than 106044.43% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PreveCeutical Medical's EBITDA for the three months ended in Dec. 2025 was €0.79 Mil. PreveCeutical Medical's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, PreveCeutical Medical's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

PreveCeutical Medical  (FRA:18H0) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PreveCeutical Medical EBITDA Margin % Related Terms

PreveCeutical Medical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PreveCeutical Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical EBITDA Margin % Chart

PreveCeutical Medical Annual Data
Trend Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PreveCeutical Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:18H0 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, PreveCeutical Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PreveCeutical Medical EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's EBITDA Margin % falls into.


PreveCeutical Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PreveCeutical Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.838/0
= %

PreveCeutical Medical's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.786/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
PreveCeutical Medical (FRA:18H0) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PreveCeutical Medical and its competitors. According to the industry distribution chart, PreveCeutical Medical ranks #999999 out of 943 companies in the Biotechnology industry.
Is PreveCeutical Medical's EBITDA Margin % too high?
PreveCeutical Medical's current EBITDA Margin % is 0.00%. Based on the distribution chart, PreveCeutical Medical ranks #999999 out of 943 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does PreveCeutical Medical's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PreveCeutical Medical ranks #999999 out of 943 companies for EBITDA Margin %. This places PreveCeutical Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PreveCeutical Medical and its competitors. PreveCeutical Medical's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (FRA:18H0) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PreveCeutical Medical (FRA:18H0), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PreveCeutical Medical Business Description

Other Exchanges PRVCF:USAPREV:Canada
Address 550 Burrard Street, Bentall 5, Suite 2501, Vancouver, BC, CAN, V6C 2B5
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.